tirzepatide acute kidney injury linked to lower risk for death, adverse CV and outcomes vs. GLP-1s A rising creatinine does NOT

View Tirzepatide Research Overview | GLP-1 Research Guide | COA & Testing Information

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects

Conversely, this trend heralds a potential boom for producers of health-oriented products like protein shakes and meal replacements, indicating a realignment of consumer preferences towards weight-management foods

In addition to their glycemic effects, DPP-4 inhibitors have the potential to decrease bone resorption, increase bone formation, and reduce the incidence of osteoporosis and fractures

Retatrutide is the only compound in advanced clinical investigation that simultaneously activates the GLP-1, GIP, and glucagon receptors

It's the first medication of its kind to work on two appetite hormones at once, which is part of the reason patients on the highest dose lost an average of 22.5% of their body weight over 72 weeks in clinical trials